A pharmacovigilance study of association between proton pump inhibitor and dementia event based on FDA adverse event reporting system data

Abstract Proton pump inhibitor (PPI) was widely used around the world. Studies suggested conflicting results between PPI treatment and dementia event. This study examined the association between six PPI agents and dementia event by mining the US FDA Adverse Event Reporting System (FAERS) database fr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bin Wu, Qiaozhi Hu, Fangyuan Tian, Fengbo Wu, Yuwen Li, Ting Xu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/73f44cc4756845329c90ca0f5afa0d53
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!